HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endogenous pro-resolving and anti-inflammatory lipid mediators: the new hope of atherosclerotic diseases.

Abstract
Atherosclerosis is a complex disease process in which genetic, lipid, cellular, and immunological factors combine to determine the location, severity, and timing of lesion development and clinical events. It has been demonstrated, however, that inflammation governed atherosclerosis during the course of development of atherosclerosis. It has also been demonstrated to be effective to decrease the cardiovascular events and improve the prognosis of atherosclerotic diseases by regulating inflammatory reaction (e.g., statins). However, endogenous mechanisms of limiting inflammation in atherosclerosis are still unclear. Recent studies showed that lipoxidase/leukotrienes (LOX/LTs) pathway played important role in the ignition and development of atherosclerosis, whereas resolvins (E-series resolvins and D-series resolvins) and protectins [protectin D1 (PD1) and neuroprotectin D1 (NPD1)], endogenous lipid-derived mediators, inhibited inflammation through pro-resolution and counter-modulating immune inflammation reaction in atherosclerosis. Hence, we hypothesize that increased endogenous lipid mediators mentioned above play a vital role in anti-atherosclerosis and plaque stabilization through pro-resolution and anti-inflammation by LOX/LTs pathway. In addition, we predict that the endogenous lipid mediators may be a new target for treatment of atherosclerotic diseases.
AuthorsYangxin Chen, Jingfeng Wang, Ruqiong Nie, Shuxian Zhou
JournalMedical hypotheses (Med Hypotheses) Vol. 71 Issue 2 Pg. 237-40 (Aug 2008) ISSN: 0306-9877 [Print] United States
PMID18448265 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Fatty Acids, Omega-3
  • Inflammation Mediators
  • Lipids
  • protectin D1
  • resolvin D1
  • Docosahexaenoic Acids
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Atherosclerosis (diagnosis, pathology)
  • Dietary Supplements
  • Docosahexaenoic Acids (metabolism)
  • Fatty Acids, Omega-3 (metabolism)
  • Humans
  • Immune System
  • Inflammation
  • Inflammation Mediators (pharmacology)
  • Lipids (chemistry)
  • Models, Biological
  • Models, Theoretical

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: